PI3K limits TNF-alpha production in CD16-activated monocytes

Area of Science:

• Immunology
• Cell Signaling
• Molecular Biology

Background:

• Immunoglobulin G (IgG) complexes engage Fc receptors (FcγRs) like FcγRI (CD64), FcγRII (CD32), and FcγRIII (CD16) on leukocytes.
• Fc receptor engagement activates mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) pathways, influencing cytokine production.

Purpose of the Study:

• To elucidate the specific signaling molecules governing cytokine production in monocytes following CD16 cross-linking.
• To investigate the interplay between MAPK, PI3K, glycogen synthase kinase-beta (GSK-3beta), and nuclear factor-kappa B (NF-kappaB) in this process.

Main Methods:

• Monocytes were activated, and cytokine levels (TNF-alpha, IL-1beta, IL-6) were measured after inhibiting MEK1/2, PI3K, and GSK-3beta.
• Reporter assays and small interfering RNA (siRNA) were employed to determine the roles of GSK-3beta and NF-kappaB.

Main Results:

• MAPK signaling stimulated TNF-alpha release, whereas active PI3K limited the production of TNF-alpha, IL-1beta, and IL-6.
• PI3K was found to inhibit NF-kappaB nuclear translocation.
• The inhibitory effect of PI3K on TNF-alpha production was linked to reduced GSK-3beta activity, which in turn decreased NF-kappaB transactivation.

Conclusions:

• CD16 cross-linking activates PI3K in monocytes.
• Active PI3K limits TNF-alpha production by suppressing GSK-3beta activity, thereby inhibiting NF-kappaB-mediated transcription.
• NF-kappaB plays a crucial role in TNF-alpha production induced by CD16 cross-linking.